ProgynyPGNY
PGNY
About: Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Employees: 566
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
43% more call options, than puts
Call options by funds: $3.47M | Put options by funds: $2.43M
1% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 97
3.1% less ownership
Funds ownership: 98.75% [Q2] → 95.65% (-3.1%) [Q3]
12% less funds holding
Funds holding: 322 [Q2] → 282 (-40) [Q3]
38% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 96
48% less capital invested
Capital invested by funds: $2.69B [Q2] → $1.4B (-$1.29B) [Q3]
57% less funds holding in top 10
Funds holding in top 10: 7 [Q2] → 3 (-4) [Q3]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$17
19%
downside
Avg. target
$18.20
13%
downside
High target
$21
0%
upside
5 analyst ratings
2 positive
40%
3 neutral
60%
0 negative
0%
JP Morgan Anne Samuel 47% 1-year accuracy 16 / 34 met price target | 19%downside $17 | Neutral Downgraded | 2 Dec 2024 |
Barclays Sarah James 18% 1-year accuracy 23 / 127 met price target | 19%downside $17 | Overweight Maintained | 14 Nov 2024 |
B of A Securities Michael Cherny 65% 1-year accuracy 24 / 37 met price target | 0%upside $21 | Buy Maintained | 13 Nov 2024 |
Canaccord Genuity Richard Close 59% 1-year accuracy 16 / 27 met price target | 19%downside $17 | Hold Maintained | 13 Nov 2024 |
Truist Securities Jailendra Singh 31% 1-year accuracy 11 / 35 met price target | 10%downside $19 | Hold Downgraded | 13 Nov 2024 |
Financial journalist opinion
Based on 7 articles about PGNY published over the past 30 days
Neutral
GlobeNewsWire
5 days ago
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women's health benefits solution, today announced the appointment of 30-year healthcare industry veteran Debra Morris to its board of directors, effective January 16, 2025.
Neutral
Business Wire
6 days ago
Securities Fraud Investigation Into Progyny, Inc. (PGNY) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROGYNY, INC. (PGNY), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On September 18, 20.
Neutral
Business Wire
1 week ago
Progyny, Inc. (PGNY) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PROGYNY, INC. (PGNY), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howa.
Neutral
PRNewsWire
1 week ago
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers.
Neutral
PRNewsWire
1 week ago
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Positive
Seeking Alpha
3 weeks ago
The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying
Progyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with strong fundamentals: $235M in cash, no debt, and 9.64% in trailing free cash flow yield. The stock's rare accumulation/momentum pattern since September and potential short squeeze kicker make it an attractive Buy.
Negative
CNBC
4 weeks ago
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.
Neutral
PRNewsWire
1 month ago
PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
SAN DIEGO , Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.
Neutral
GlobeNewsWire
1 month ago
Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
Positive
CNBC Television
1 month ago
Four hidden gems in the stock market from a five-star fund manager
Investors might be well served by expanding beyond the S&P 500.
Charts implemented using Lightweight Charts™